| IL | HB4874 | Pass | Amends the Illinois Controlled Substances Act. Provides that a pharmacist may not refuse to fill a valid prescription solely because it is not prescribed electronically. Provides that a compliance action with respect to this provision initiated by th...
[Detail][Text][Discuss] | 2024-08-02
Public Act . . . . . . . . . 103-0732 |
| IL | HB5285 | Pass | Reinserts the provisions of the introduced bill, except in the definition of "conviction" in the Criminal Code of 2012, restores a provision that "conviction" means a judgment of conviction or sentence (rather than a judgment of conviction and senten...
[Detail][Text][Discuss] | 2024-07-19
Public Act . . . . . . . . . 103-0702 |
| IL | HB0001 | Intro
25% | Creates the Compassionate Use and Research of Entheogens Act. Establishes the Illinois Psilocybin Advisory Board within the Department of Public Health for the purpose of advising and making recommendations to the Department regarding the provision o...
[Detail][Text][Discuss] | 2024-05-22
To House Rules Committee |
| IL | HB4628 | Intro
25% | Amends the Illinois Controlled Substances Act. Schedules Tianeptine as a Schedule III controlled substance.
[Detail][Text][Discuss] | 2024-04-19
To House Rules Committee |
| IL | HB3721 | Intro
25% | Reinserts the provisions of the introduced bill with the following changes. Replaces references to "naturopathic physician" with "naturopathic doctor". Authorizes licensees under the Act to only use certain titles. Adds a provision requiring naturopa...
[Detail][Text][Discuss] | 2024-04-19
To House Rules Committee |
| IL | HB4450 | Intro
25% | Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides that notwithstanding the scheduling of xylazine as a Schedule III controlled substance, xylazine shall not be considered a controlled s...
[Detail][Text][Discuss] | 2024-04-19
To House Rules Committee |
| IL | HB5373 | Engross
50% | Amends the Illinois Controlled Substances Act. Provides that decisions regarding the treatment of patients experiencing chronic pain shall be made by the prescriber with dispensing by the pharmacist in accordance with the corresponding responsibility...
[Detail][Text][Discuss] | 2024-04-19
To Senate Assignments Committee |
| IL | HB3180 | Intro
25% | Amends the Illinois Controlled Substances Act. Adds Clonazolam as a Schedule IV controlled substance.
[Detail][Text][Discuss] | 2024-04-05
To House Rules Committee |
| IL | HB4352 | Intro
25% | Amends the Illinois Controlled Substances Act. Provides that Xylazine and Clonazolam are to be regulated under the Act as Schedule II controlled substances.
[Detail][Text][Discuss] | 2024-04-05
To House Rules Committee |
| IL | HB4637 | Intro
25% | Amends the Physician Assistant Practice Act of 1987. Provides that a physician assistant may prescribe, dispense, order, administer, and procure drugs and medical devices without delegation of authority by a physician. Provides that a physician assis...
[Detail][Text][Discuss] | 2024-04-05
To House Rules Committee |
| IL | HB3210 | Intro
25% | Amends the Illinois Controlled Substances Act. Provides that in addition to any other penalties provided by law, a person knowingly and unlawfully selling or dispensing any scheduled drug containing a detectable amount of fentanyl is guilty of a Clas...
[Detail][Text][Discuss] | 2024-02-23
To House Rules Committee |
| IL | HB4694 | Intro
25% | Amends the Illinois Controlled Substances Act. Provides that if a controlled substance analog is at least 5 times as potent as the controlled substance of which it is an analog, then the weight of the controlled substance analog for purposes of the A...
[Detail][Text][Discuss] | 2024-02-06
To House Rules Committee |
| IL | HB4331 | Intro
25% | Amends the Illinois Controlled Substances Act. Increases the penalties by 3 years for a minimum sentence and 10 years for a maximum sentence for the knowing manufacture or delivery or possession with intent to manufacture or deliver 15 grams or more ...
[Detail][Text][Discuss] | 2024-02-01
To House Rules Committee |
| IL | HB4479 | Intro
25% | Amends the Illinois Controlled Substances Act. Provides that a person who reasonably believes that another person is experiencing an overdose and knowingly fails to seek emergency medical assistance for that person is guilty of a Class 4 felony unles...
[Detail][Text][Discuss] | 2024-01-17
To House Rules Committee |
| IL | HB2046 | Intro
25% | Amends the Illinois Controlled Substances Act. Provides that all decisions regarding the treatment of patients experiencing pain, including chronic pain, shall be made by the prescriber. Provides that ordering, prescribing, dispensing, administering,...
[Detail][Text][Discuss] | 2023-11-29
To House Rules Committee |
| IL | HB2289 | Pass | Creates the First 2023 General Revisory Act. Combines multiple versions of Sections amended by more than one Public Act. Renumbers Sections of various Acts to eliminate duplication. Corrects obsolete cross-references and technical errors. Makes styli...
[Detail][Text][Discuss] | 2023-06-30
Public Act . . . . . . . . . 103-0154 |
| IL | HB2414 | Intro
25% | Amends the Illinois Controlled Substances Act. Increases the penalties by 3 years for a minimum sentence and 10 years for a maximum sentence for the knowing manufacture or delivery or possession with intent to manufacture or deliver 15 grams or more ...
[Detail][Text][Discuss] | 2023-06-09
To House Rules Committee |
| IL | HB2306 | Intro
25% | Amends the Physician Assistant Practice Act of 1987. Changes the definition of "physician assistant", "physician assistant practice", "board", and "collaborating physician". Removes the definition of "disciplinary board" and changes references from t...
[Detail][Text][Discuss] | 2023-03-15
To House Rules Committee |
| IL | HB3873 | Intro
25% | Amends the Illinois Controlled Substances Act. Schedules xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isom...
[Detail][Text][Discuss] | 2023-03-10
To House Rules Committee |
